Life Bridge Innovations Pbc announced it raised $45,400 in an initial filing from an offering of $4.03 Million

Company

Location

About

LifeBridge Innovations, PBC is on a mission to transform metastatic cancer from a terminal prognosis into a manageable chronic condition, similar to diabetes. The company is advancing its patented Adaptive Tumor Treating Field (ATTF) therapy, which it believes could become the standard of care for metastatic diseases in the torso within five years of commercial launch. LifeBridge is currently preparing for animal safety trials and has developed a fully FDA-vetted clinical protocol for its upcoming Human Pilot Clinical Trial. Notably, the FDA has granted the company Basket Trial status, allowing the inclusion of up to 14 different types of cancer within a single study—marking a first for any TTF-based trial.